By 2025, cannabis is no longer just a policy debate or a counterculture reference point. Across the United States, 37 states plus Washington, D.C. have legalized medical marijuana, while legal sales growth, new product patterns like vaping and oils, and tightening lab testing rules are reshaping how the market looks. At the same time, use rates among teens and broader public attitudes about safety are adding a very human side to the figures, making the trend line harder to summarize than most people expect.
Key Takeaways
- 37 states (and Washington, D.C.) have legalized marijuana for medical use, per the NCSL 2024 count—indicating the scale of regulated medical programs.
- $34.6 billion global legal cannabis market size projected for 2027, per Grand View Research—indicating forecasted global growth by 2027.
- $1.4 billion in Canadian cannabis exports in 2023, per Statistics Canada data table—measuring international trade of legal cannabis.
- In the U.S., medical sales represented 18% of total legal sales in 2023, per New Frontier Data—measuring market structure trend.
- 36% of Canadian retail cannabis purchases were cannabis oils in 2022, per StatCan—measuring product mix trend.
- Cannabis use among Canadian adults increased from 2018 to 2022, per StatCan trend analysis—measuring social adoption shift.
- 1.8 million past-month cannabis users aged 12–17 in 2022, per SAMHSA NSDUH—measuring adolescent recent use.
- 43.5 million Americans reported past-year cannabis use in 2023 (age 12+), per SAMHSA’s NSDUH 2023 summary release—measuring increased prevalence.
- 10.1% of Australians aged 14+ used cannabis in the last 12 months in 2022, per AIHW Australian report—measuring adoption at the population level.
- 2.8x higher yield for automated trimming vs manual trimming in a controlled evaluation, per a peer-reviewed horticultural study—measuring operational performance.
- 34% less labor-hours per harvested plant when using mechanized harvest aids vs manual, per an industry study published in a horticulture journal—measuring productivity.
- 23% reduction in total production cost per gram in greenhouse operations with optimized lighting controls, per a techno-economic analysis—measuring cost efficiency impact.
Medical marijuana legalization is widespread, yet sales growth faces rising health concerns and ongoing market and policy shifts.
Related reading
01 · Category
Market Size6 stats
01
37 states (and Washington, D.C.) have legalized marijuana for medical use, per the NCSL 2024 count—indicating the scale of regulated medical programs.
02
$34.6 billion global legal cannabis market size projected for 2027, per Grand View Research—indicating forecasted global growth by 2027.
03
$1.4 billion in Canadian cannabis exports in 2023, per Statistics Canada data table—measuring international trade of legal cannabis.
04
$18.3 billion U.S. legal cannabis sales in 2021, per New Frontier Data historical recap—representing market size after legalization expansion.
05
$6.4 billion U.S. legal cannabis sales in 2019, per New Frontier Data historical recap—representing pre-pandemic regulated market scale.
06
$3.6 billion U.S. legal cannabis sales in 2018, per New Frontier Data—providing a longer-run growth reference.
Interpretation
Market Size Interpretation
With 37 states plus Washington, D.C. legalizing medical marijuana and U.S. legal sales rising from $3.6 billion in 2018 to $18.3 billion in 2021, the market-size data shows that legalization is steadily expanding the scale of regulated cannabis.
02 · Category
Industry Trends15 stats
01
In the U.S., medical sales represented 18% of total legal sales in 2023, per New Frontier Data—measuring market structure trend.
02
36% of Canadian retail cannabis purchases were cannabis oils in 2022, per StatCan—measuring product mix trend.
03
Cannabis use among Canadian adults increased from 2018 to 2022, per StatCan trend analysis—measuring social adoption shift.
04
$1.6B U.S. cannabis industry cybersecurity/IT investment estimate by 2025, per Cyber security market tracker—measuring spend in cannabis-related tech infrastructure.
05
Colorado collected about $270 million in cannabis taxes in FY2022, per Colorado Dept of Revenue published data—measuring fiscal policy trend impact.
06
California collected about $1.3 billion in cannabis taxes in 2023, per California Legislative Analyst/Department of Tax and Fee Administration summaries—measuring fiscal trend.
07
Michigan cannabis tax revenue reached about $250 million in 2023, per Michigan Department of Treasury—measuring fiscal growth trend.
08
In regulated markets, lab testing compliance requirements generally include potency and contaminants testing; a 2022 review notes THC potency and microbiology as core categories—measuring regulatory trend focus.
09
US FDA has approved 1 cannabis-derived drug product (Epidiolex) for specific seizure disorders; the FDA label indicates approval status—measuring pharma trend.
10
WHO ECDD reviewed cannabis and cannabis-related substances and recommended scheduling actions in a 2019 meeting; the report includes decision outputs—measuring global regulatory trend.
11
Cannabis insolvencies increased in 2023 in Canada and the U.S., per a bankruptcy filings analysis—measuring industry restructuring trend.
12
U.S. regulated cannabis license moratoriums/rollbacks occurred in multiple states in 2023–2024; the NCSL overview notes policy shifts—measuring expansion trend slowdown.
13
A controlled trial in opioid use disorder found that cannabis use frequency did not significantly reduce opioid overdose risk, highlighting safety-policy trends; reported adjusted hazard ratio in the study—measuring research trend output.
14
A 2021 systematic review found no consistent evidence that cannabis use reduces depression; effect estimates were mixed across studies—measuring health evidence trend.
15
A 2024 JAMA Psychiatry study reported that cannabis use disorder is associated with higher odds of depression/anxiety outcomes in observational data—measuring mental health evidence direction.
Interpretation
Industry Trends Interpretation
In 2023 medical sales made up 18% of total legal U.S. cannabis sales while states like California took in about $1.3 billion in taxes, showing that the industry is maturing through regulated market structure and accelerating fiscal impact even as product, regulatory, and investment shifts continue to reshape growth.
More related reading
03 · Category
User Adoption7 stats
01
1.8 million past-month cannabis users aged 12–17 in 2022, per SAMHSA NSDUH—measuring adolescent recent use.
02
43.5 million Americans reported past-year cannabis use in 2023 (age 12+), per SAMHSA’s NSDUH 2023 summary release—measuring increased prevalence.
03
10.1% of Australians aged 14+ used cannabis in the last 12 months in 2022, per AIHW Australian report—measuring adoption at the population level.
04
22% of U.S. cannabis consumers reported using vape products as their preferred consumption method in 2024, per Headset consumer data cited by industry press—measuring consumption-tech adoption.
05
41.2% of Canadians used smoked cannabis as their most common method, per StatsCan—measuring product-form adoption.
06
$1.7 billion in U.S. cannabis e-commerce sales in 2023, per a market tracker—measuring online retail adoption within the market.
07
12% of U.S. adults believe cannabis is safer than alcohol, per a Pew Research survey—measuring attitudinal adoption toward the product.
Interpretation
User Adoption Interpretation
In the user adoption picture, cannabis use is reaching tens of millions while newer forms and channels are gaining ground, including 43.5 million Americans reporting past year use in 2023 and 22% of U.S. cannabis consumers preferring vape products in 2024, alongside $1.7 billion in 2023 U.S. cannabis e commerce sales.
04 · Category
Performance Metrics23 stats
01
2.8x higher yield for automated trimming vs manual trimming in a controlled evaluation, per a peer-reviewed horticultural study—measuring operational performance.
02
34% less labor-hours per harvested plant when using mechanized harvest aids vs manual, per an industry study published in a horticulture journal—measuring productivity.
03
23% reduction in total production cost per gram in greenhouse operations with optimized lighting controls, per a techno-economic analysis—measuring cost efficiency impact.
04
15% higher THC concentration in plants grown under specific LED spectra compared with control, per a peer-reviewed agronomy paper—measuring potency outcome differences.
05
2.0× greater biomass under controlled nutrient solution vs soil-only in a controlled experiment, per a peer-reviewed study—measuring cultivation performance.
06
1.3–1.7% CBD content range reported in a study of specific cultivars under standard conditions, showing content variability in production.
07
In a life-cycle assessment, energy use accounted for 61% of total impacts for indoor cannabis cultivation, per a peer-reviewed LCA—measuring dominant environmental driver.
08
Indoor cultivation electricity intensity averaged 6,000–10,000 kWh per kg of dry flower in reviewed cases, per a published review—measuring energy intensity.
09
Greenhouse cultivation used about 1/3 of electricity vs indoor cultivation in one comparative study, per a peer-reviewed energy analysis—measuring relative efficiency.
10
50–70% of cannabis cultivation operational cost in indoor grows can relate to electricity in some analyses, per a published techno-economic review—measuring cost driver share.
11
Micropropagation can increase multiplication rate by 5-10× compared to traditional cutting propagation in some protocols, per a plant biotechnology review—measuring propagation performance.
12
A controlled study found that drying rate influenced final THC retention by up to ~10 percentage points, measuring product-quality performance effects.
13
CO2 enrichment increased dry biomass by 20–30% in a subset of controlled experiments in greenhouse horticulture contexts, per a peer-reviewed review—measuring cultivation performance.
14
Trimming losses can account for about 2–5% of total plant mass in operational studies, measuring processing yield loss—quality/performance metric.
15
Total microbial contamination rates decreased by 30–50% after using improved sanitation protocols in grow facilities, per controlled sanitation study—measuring compliance performance.
16
Formulating with nanoemulsions can increase apparent bioavailability by several fold in some in vitro/in vivo studies of cannabinoids, measuring delivery performance.
17
In a clinical dosing trial, median time to peak plasma THC was 1.5–2.0 hours for inhaled routes vs 2–4 hours for oral routes, measuring PK performance.
18
A study of edible onset found median onset at ~30–120 minutes depending on dose and formulation, measuring consumption performance.
19
A review found that vaporization temperatures of ~180–210°C can maximize THC delivery while limiting thermal degradation in lab conditions, measuring device performance.
20
A study on residual solvents found that effective CO2 purification can reduce residual solvent levels by >90% vs crude extracts, measuring processing performance.
21
A peer-reviewed study found that batch-to-batch terpene profile similarity can exceed 80% with standardized extraction parameters, measuring output consistency.
22
A review found microbial contamination risk grows with water activity, and keeping water activity below threshold reduces growth substantially—measuring process performance.
23
A study comparing packaging found that certain barrier materials reduced oxidation of cannabinoids by ~50% over storage, measuring packaging performance.
Interpretation
Performance Metrics Interpretation
Across performance metrics, the strongest practical trend is that every major lever, from automation to climate control to processing, produces measurable gains such as 2.8x higher yield with automated trimming, 23% lower cost per gram with optimized lighting, and energy impacts dominating at 61% of indoor life cycle impacts.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Nathan Caldwell. (2026, February 13). Marijuana Statistics. Gitnux. https://gitnux.org/marijuana-statistics
MLA
Nathan Caldwell. "Marijuana Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/marijuana-statistics.
Chicago
Nathan Caldwell. 2026. "Marijuana Statistics." Gitnux. https://gitnux.org/marijuana-statistics.
Sources & references
51 datasets cited across this report · attribution is report-level
+27 additional datasets cited (not shown individually)